Holen Sie sich die Stockscreener-App
80.49
23.23%
-24.35
Handel nachbörslich:
80.75
0.26
+0.32%
Schlusskurs vom Vortag:
$104.84
Offen:
$89.9
24-Stunden-Volumen:
7.23M
Relative Volume:
7.48
Marktkapitalisierung:
$7.16B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$427.61M
KGV:
13.39
EPS:
6.01
Netto-Cashflow:
$423.98M
1W Leistung:
-22.86%
1M Leistung:
-15.67%
6M Leistung:
-8.86%
1J Leistung:
+5.89%
1-Tages-Spanne:
$79.24
$89.90
1-Wochen-Bereich:
$79.24
$108.91
52-Wochen-Spanne:
$74.28
$126.89
Lantheus Holdings Inc Stock (LNTH) Company Profile
Firmenname
Lantheus Holdings Inc
Sektor
Telefon
978 671-8001
Adresse
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Vergleichen Sie LNTH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNTH
Lantheus Holdings Inc
|
80.49 | 7.16B | 1.50B | 427.61M | 423.98M | 6.01 |
|
ZTS
Zoetis Inc
|
155.99 | 69.76B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.06 | 48.12B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.76 | 45.75B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.60 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
306.92 | 13.67B | 2.76B | 1.11B | 898.10M | 22.77 |
Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-18 | Eingeleitet | Goldman | Buy |
| 2024-09-03 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-07-10 | Bestätigt | JMP Securities | Mkt Outperform |
| 2023-12-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-12-04 | Eingeleitet | TD Cowen | Outperform |
| 2023-09-29 | Eingeleitet | William Blair | Outperform |
| 2023-03-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-11-30 | Eingeleitet | SVB Leerink | Outperform |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-05-09 | Eingeleitet | B. Riley Securities | Buy |
| 2022-04-13 | Eingeleitet | Truist | Buy |
| 2021-02-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-29 | Fortgesetzt | Jefferies | Buy |
| 2019-08-16 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2017-11-02 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-11-08 | Bestätigt | RBC Capital Mkts | Outperform |
| 2016-09-23 | Fortgesetzt | Credit Suisse | Neutral |
| 2016-02-24 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-12-11 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2015-09-30 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2015-07-20 | Eingeleitet | Credit Suisse | Outperform |
| 2015-07-20 | Eingeleitet | Jefferies | Buy |
| 2015-07-20 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-07-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-20 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Lantheus Holdings Inc Aktie (LNTH) Neueste Nachrichten
Lantheus Holdings Earnings Call: Mixed Outlook Amid Strategic Moves - TipRanks
Balancing Challenges and Opportunities: Justin Walsh’s Optimistic Buy Rating for Lantheus Holdings Amidst Strategic Reorganization - TipRanks
Lantheus Holdings, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsLNTH - Business Wire
Shine to buy Lantheus’ SPECT business - AuntMinnie
Lantheus Holdings: Q1 Earnings Snapshot - MySA
Lantheus announces pivotal trial win for Alzheimer’s imaging agent - MSN
Lantheus Holdings (LNTH) Stock Drops After Lowering 2025 Outlook - GuruFocus
Lantheus Holdings stock drops on lowered full year outlook - MSN
Lantheus Holdings (LNTH) Revises 2025 Revenue Guidance Amid Strategic Shifts - GuruFocus
Lantheus stock down on guidance cut (LNTH:NASDAQ) - Seeking Alpha
Transcript : Lantheus Holdings, Inc., Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Earnings call transcript: Lantheus Q1 2025 results miss estimates, stock drops - Investing.com
Lantheus Holdings (LNTH) Misses Q1 Earnings and Revenue Estimates - GuruFocus
Lantheus' Q1 Adjusted Earnings Fall, Revenue Rises; Trims 2025 Adjusted Earnings Guidance - marketscreener.com
Lantheus Holdings Inc Reports Q1 2025 Earnings: Adjusted EPS of $1.53 Beats Estimates, Revenue of $372.8 Million Misses Expectations - GuruFocus
Lantheus (LNTH) Reports Q1 Revenue and Strategic Acquisitions | LNTH Stock News - GuruFocus
Lantheus Holdings, Inc. SEC 10-Q Report - TradingView
Lantheus Q1 2025 slides: Revenue flat, EPS down as company focuses on acquisitions - Investing.com India
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Lantheus Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Lantheus to sell SPECT Business to SHINE Technologies - MSN
Lantheus announces plans to divest SPECT imaging business - Radiology Business
Lantheus Announces Sale of SPECT Business to SHINE Technologies - The Manila Times
Lantheus divests SPECT business to SHINE Technologies - Investing.com
SHINE Technologies Announces Plan to Acquire Lantheus' SPECT Division, Expanding Market Reach and Leadership in Nuclear Medicine - Yahoo Finance
Lantheus Earnings: What To Look For From LNTH - Yahoo Finance
Lantheus Holdings (NasdaqGM:LNTH) Advances Alzheimer's PET Diagnostic With Successful Trial Results - Yahoo Finance
Lantheus (LNTH) Advances Alzheimer's Imaging Agent MK-6240 - GuruFocus
Fund Update: BRIDGES INVESTMENT MANAGEMENT INC added 13,439 shares of LANTHEUS HOLDINGS ($LNTH) to their portfolio - Nasdaq
Lantheus Says Alzheimer's Disease Radiodiagnostic MK-6240 Meets Primary Endpoints in Two Trials - marketscreener.com
Lantheus (LNTH) Achieves Key Milestones with MK-6240 Radiodiagno - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool By Investing.com - Investing.com India
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 M - GuruFocus
Lantheus to file NDA for Alzheimer’s diagnostic tool - Investing.com Australia
Lantheus Announces Alzheimer's Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies - The Manila Times
Lantheus Holdings, Inc. Announces Positive Results for MK-6240, a Potential Alzheimer's Disease Diagnostic Tool - Nasdaq
Lantheus Announces Alzheimer's Disease Radiodiagnostic Mk-6240 Meets Co-Primary Endpoints In Two Pivotal Studies - marketscreener.com
Lantheus's Revolutionary Alzheimer's Brain Scan Hits Major Milestone, FDA Filing Next - Stock Titan
Lantheus Holdings, Inc. (LNTH): Among Stocks with Consistent Growth to Buy Now - MSN
Breaking News: FDA Approves a Highly Sensitive Prostate Cancer Imaging Agent - PCF | Prostate Cancer Foundation
Lantheus Holdings Inc (LNTH) Shares Gap Down to $100.08 on Apr 2 - GuruFocus
Press Release Distribution & PR Platform - ACCESS Newswire
11 Stocks with Consistent Growth to Buy Now - Insider Monkey
Lantheus to Host First Quarter 2025 Earnings Conference Call and - GuruFocus
Lantheus Holdings, Inc. Announces Conference Call to Discuss Q1 2025 Financial Results - Nasdaq
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time - The Manila Times
Lantheus Q1 2025 Earnings Call: How to Join the May 7 Investor Presentation - Stock Titan
Lantheus Holdings, Inc. (NASDAQ:LNTH) Shares Could Be 44% Below Their Intrinsic Value Estimate - simplywall.st
In tough environment, Lantheus has cash and plans to use it - The Business Journals
(LNTH) Proactive Strategies - news.stocktradersdaily.com
Lantheus at Jones Healthcare Conference: Radiopharma Roadmap Insights By Investing.com - Investing.com India
Finanzdaten der Lantheus Holdings Inc-Aktie (LNTH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):